MagAssist

MagAssist is a groundbreaking startup in the health care industry, founded in 2017 by Dr. Xu Bozhen—a distinguished expert in the National Youth Thousand People Program and a professor at Suzhou University. The company is dedicated to advancing a leading in vitro short-term ventricular assist device, a type of artificial heart. Its core team, comprising top-tier experts in artificial heart engineering technology, has extensive experience in international artificial heart R&D and commercialization. Notably, MagAssist has successfully developed a domestically produced artificial heart with independent intellectual property rights. The latest milestone for MagAssist came on 18 October 2021 with a significant CNY500.00M Series C investment led by prominent venture capital firms including Sequoia China, CH Innovations, and Cenova Capital. This substantial investment affirms the potential and value of MagAssist's innovative approach to in vitro short-term ventricular assist devices. With this funding, MagAssist is well positioned to further develop its technology, expand its market presence, and make a meaningful impact on the health care industry.